Product information

Current status:

Cancelled Pre Market

Current status date:

2017-09-12

Original market date: ^{See footnote 1}

Product name:

ETOPOSIDE

DIN:

02237873 Electronic product monograph is not available

Company:

PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada H4P 2T4

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

10:00.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

L01CB01 ETOPOSIDE

Active ingredient group (AIG) number:^{See footnote5}

0114567002